Zobrazeno 1 - 10
of 5 029
pro vyhledávání: '"Kuperwasser, C"'
Autor:
Huffman BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Singh H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ali LR; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Horick N; Massachusetts General Hospital, Boston, Massachusetts, USA., Wang SJ; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hoffman MT; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Metayer KA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Murray S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Bird A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Abrams TA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Biller LH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Chan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Goessling W; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Patel AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Wisch JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Yurgelun MB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Mouw K; Harvard Medical School, Boston, Massachusetts, USA., Reardon B; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Zerillo JA; Harvard Medical School, Boston, Massachusetts, USA.; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Clark JW; Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Parikh A; Massachusetts General Hospital, Boston, Massachusetts, USA., Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Schlechter B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Kumar S; Naveris, Inc, Waltham, Massachusetts, USA., Del Vecchio Fitz C; Naveris, Inc, Waltham, Massachusetts, USA., Kuperwasser C; Naveris, Inc, Waltham, Massachusetts, USA., Hanna GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Coveler AL; University of Washington School of Medicine, Seattle, Washington, USA., Rubinson DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Welsh EL; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Pfaff K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu., Dougan SK; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu., Cleary JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA James_Cleary@dfci.harvard.edu stephanie_dougan@dfci.harvard.edu srodig@bwh.harvard.edu.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jan 25; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 25.
Autor:
Kim HY; Department of Developmental, Chemical & Molecular Biology, Tufts University, Boston, MA 02111, USA., Sinha I; Department of Ecology and Evolutionary Biology, University of California at Los Angeles, Los Angeles, CA 90095, USA., Sears KE; Department of Ecology and Evolutionary Biology, University of California at Los Angeles, Los Angeles, CA 90095, USA., Kuperwasser C; Department of Developmental, Chemical & Molecular Biology, Tufts University, Boston, MA 02111, USA.; Laboratory for the Convergence of Biomedical, Physical, and Engineering Sciences, Tufts University School of Medicine, Boston, MA 02111, USA., Rauner G; Department of Developmental, Chemical & Molecular Biology, Tufts University, Boston, MA 02111, USA.
Publikováno v:
Development (Cambridge, England) [Development] 2024 Jan 15; Vol. 151 (2). Date of Electronic Publication: 2024 Jan 26.
Autor:
Batool S; Harvard Medical School, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA., Sethi RKV; Harvard Medical School, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wang A; Harvard Medical School, Boston, MA, USA., Dabekaussen K; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Department of Surgery, Amsterdam Medical Center, Amsterdam University, the Netherlands., Egloff AM; Harvard Medical School, Boston, MA, USA; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Del Vecchio Fitz C; Naveris, Inc., Natick, MA, USA., Kuperwasser C; Naveris, Inc., Natick, MA, USA., Uppaluri R; Harvard Medical School, Boston, MA, USA; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shin J; Harvard Medical School, Boston, MA, USA; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rettig EM; Harvard Medical School, Boston, MA, USA; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Center for Head and Neck Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: emrettig@bwh.harvard.edu.
Publikováno v:
Oral oncology [Oral Oncol] 2023 Dec; Vol. 147, pp. 106584. Date of Electronic Publication: 2023 Oct 12.
Autor:
Hanna GJ; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Roof SA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Jabalee J; Naveris, Inc., Natick, Massachusetts., Rettig EM; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Ferrandino R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Chen S; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Posner MR; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Misiukiewicz KJ; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Genden EM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Chai RL; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Sims J; CARTI Cancer Center, Little Rock, Arkansas., Thrash E; CARTI Cancer Center, Little Rock, Arkansas., Stern SJ; CARTI Cancer Center, Little Rock, Arkansas., Kalman NS; Miami Cancer Institute, Miami, Florida., Yarlagadda S; Miami Cancer Institute, Miami, Florida., Raben A; Christiana Care, Helen F. Graham Cancer Center and Research Institute, Newark, Delaware., Clements L; The U.S. Oncology Network, Inc., Woodlands, Texas., Mendelsohn A; David Geffen School of Medicine at University of California, Los Angeles, California., Kaczmar JM; Medical College of South Carolina Health-University Medical Center, Charleston, South Carolina., Pandey Y; Medical College of South Carolina Health-University Medical Center, Charleston, South Carolina., Bhayani M; Rush University Medical Center, Chicago, Illinois., Gupta P; Naveris, Inc., Natick, Massachusetts., Kuperwasser C; Naveris, Inc., Natick, Massachusetts., Del Vecchio Fitz C; Naveris, Inc., Natick, Massachusetts., Berger BM; Naveris, Inc., Natick, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 13; Vol. 29 (20), pp. 4306-4313.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Oct 11. Date of Electronic Publication: 2023 Oct 11.
Autor:
Rettig EM; Division of Otolaryngology-Head and Neck Surgery, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Center for Head and Neck Oncology, Boston, MA, USA; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA. Electronic address: emrettig@bwh.harvard.edu., Waterboer T; Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Sim E; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA; Massachusetts Eye and Ear, Boston, MA, USA., Faden DL; Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, MA, USA; Massachusetts Eye and Ear, Boston, MA, USA; Massachusetts General Hospital, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Butt J; Division of Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hanna GJ; Dana-Farber Center for Head and Neck Oncology, Boston, MA, USA., Del Vecchio Fitz C; Naveris Inc., Natick, MA, USA., Kuperwasser C; Naveris Inc., Natick, MA, USA., Sroussi H; Dana-Farber Center for Head and Neck Oncology, Boston, MA, USA; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA.
Publikováno v:
Oral oncology [Oral Oncol] 2023 Jun; Vol. 141, pp. 106417. Date of Electronic Publication: 2023 May 04.
Autor:
Gunning A; Naveris, Waltham, MA 02451, USA., Kumar S; Naveris, Waltham, MA 02451, USA., Williams CK; Naveris, Waltham, MA 02451, USA., Berger BM; Naveris, Waltham, MA 02451, USA., Naber SP; Naveris, Waltham, MA 02451, USA., Gupta PB; Naveris, Waltham, MA 02451, USA., Del Vecchio Fitz C; Naveris, Waltham, MA 02451, USA., Kuperwasser C; Naveris, Waltham, MA 02451, USA.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 Feb 14; Vol. 13 (4). Date of Electronic Publication: 2023 Feb 14.
Autor:
Skibinski, A, Kuperwasser, C
Publikováno v:
Oncogene. 10/15/2015, Vol. 34 Issue 42, p5309-5316. 8p. 2 Diagrams.
Autor:
Echevarria, M., Caudell, J., Kim, Y., Yang, G., Kumar, S., Kuperwasser, C., Del Vecchio Fitz, C., Giuliano, A., Chung, C.
Publikováno v:
In Radiotherapy and Oncology May 2023 182 Supplement 1:S718-S718
Autor:
Berger BM; Naveris, Inc., Natick, Massachusetts., Hanna GJ; Center for Salivary and Rare Head and Neck Cancers, Head and Neck Oncology Program, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Posner MR; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Genden EM; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York., Lautersztain J; Florida Cancer Specialists and Research Institute, Tampa, Florida., Naber SP; Naveris, Inc., Natick, Massachusetts., Del Vecchio Fitz C; Naveris, Inc., Natick, Massachusetts., Kuperwasser C; Naveris, Inc., Natick, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Oct 03; Vol. 28 (19), pp. 4292-4301.